BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE270.557.45 (+2.83 %)
PREV CLOSE ( ) 263.10
OPEN PRICE ( ) 272.25
BID PRICE (QTY) 270.40 (40)
OFFER PRICE (QTY) 270.60 (267)
VOLUME 117248
TODAY'S LOW / HIGH ( )269.00 273.00
52 WK LOW / HIGH ( )217.5 307
NSE270.306.55 (+2.48 %)
PREV CLOSE( ) 263.75
OPEN PRICE ( ) 271.90
BID PRICE (QTY) 270.20 (50)
OFFER PRICE (QTY) 270.30 (1477)
VOLUME 2780523
TODAY'S LOW / HIGH( ) 269.00 273.00
52 WK LOW / HIGH ( )217.5 307.1
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.